Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Katia B.B. Pagnano, MD PhD, Paola Morelato Assunção, MD, Roberto Zullli, Marcia T Delamain, MD, Gislaine OLIVEIRA Duarte, Irene Lorand-Metze, MD PhD, Carmino A De Souza, Sr., MD PhD

Blood (2015) 126 (23): 4031.

https://doi.org/10.1182/blood.V126.23.4031.4031

Published: 2015

Journal Articles

Evaluation of Peroxiredoxins (PRDX1, PRDX2 and PRDX6) Expression in Patients with Chronic Myeloid Leukemia (CML) Treated with Imatinib in First Line

Cintia Mascarenhas, Lara Woldmar, Maria Helena Almeida, PhD, Rosangela Vieira Andrade, PhD, Anderson Ferreira Cunha, Carmino A De Souza, MD PhD

Blood (2014) 124 (21): 5545.

https://doi.org/10.1182/blood.V124.21.5545.5545

Published: 2014

Journal Articles

Predictive Value Of Early Molecular Responses In Outcomes Of Patients With Chronic Myeloid Leukemia Treated With Imatinib In First-Line Therapy

Katia B. Pagnano, MD, PhD, Bruna Vergilio, Eliana C M Miranda, MEd, Marcia Torresan Delamain, MD, Maria Helena De Almeida, RN, Vagner O Duarte, Gislaine O. Duarte, PhD, Carmino A De Souza, Sr., MD, PhD, Irene Lorand-Metze, MD, PhD

Blood (2013) 122 (21): 4941.

https://doi.org/10.1182/blood.V122.21.4941.4941

Published: 2013

Journal Articles

Evaluation Of hOCT1expression In Patients With Chronic Myeloid Leukemia (CML) Treated With Imatinib In First Line

Cintia Do Couto Mascarenhas, PhD, Maria Helena Almeida, PhD, Eliana C M Miranda, MEd, Bruna Virgilio, Marcia Torresan Delamain, MD, Gislaine O. Duarte, PhD, Vagner O Duarte, Carmino A De Souza, Sr., MD, PhD, Katia B. Pagnano, MD, PhD

Blood (2013) 122 (21): 4041.

https://doi.org/10.1182/blood.V122.21.4041.4041

Published: 2013

Journal Articles

Multiple Myeloma Profile In Latin America: Clinical and Epidemiological Observational Study

Blood (2013) 122 (21): 5327.

https://doi.org/10.1182/blood.V122.21.5327.5327

Published: 2013

Journal Articles

Early Molecular Response Is Predictive Of Overall, Progression-Free and Event-Free Survival In Chronic Myeloid Leukemia Using Second-Generation Tyrosine Kinase Inhibitors After Imatinib Treatment

Beatriz F Ribeiro, Bruna Vergilio, Eliana C M Miranda, MEd, Maria Helena Almeida, RN, Marcia Torresan Delamain, MD, Rosana A Silveira, MSc, Carmino A De Souza, Sr., MD, PhD, Dulcinéia Martins Albuquerque, BSc, MSc, PhD, Andrey dos Santos, PhD, Irene Lorand-Metze, MD, PhD, Vagner O Duarte, Gislaine O. Duarte, PhD, Katia B. Pagnano, MD, PhD

Blood (2013) 122 (21): 1326.

https://doi.org/10.1182/blood.V122.21.1326.1326

Published: 2013

Journal Articles

Metabolomic Model For Chronic Gvhd Diagnosis

Marcos Rodrigo Alborghetti, Sr., PhD, Maria Elvira P Corrêa, DDS, PhD, Andreia Aparecida da Silva, DDS, PhD, Eliana C M Miranda, MEd, Carmino A De Souza, Sr., MD, PhD, Mauricio L Sforça, Sr., PhD, Ana Carolina de Mattos Zeri, PhD

Blood (2013) 122 (21): 3304.

https://doi.org/10.1182/blood.V122.21.3304.3304

Published: 2013

Journal Articles

Treatment Results With Dasatinib Or Nilotinib In Third Line Therapy Of Chronic Myeloid Leukemia After Failure Of Two Tyrosine Kinase Inhibitors

Beatriz F Ribeiro, Eliana C M Miranda, MEd, Marcia T Delamain, MD, Gislaine Borba Oliveira, MD,, Maria Helena Almeida, RN, Vagner O Duarte, Irene L Metze, MD, PhD, Carmino A De Souza, Sr., MD, PhD, Rosana A Silveira, Katia B. Pagnano, MD, PhD

Blood (2013) 122 (21): 5189.

https://doi.org/10.1182/blood.V122.21.5189.5189

Published: 2013

Journal Articles

Evaluation Of Anemia After Long-Term Treatment With Imatinib In Chronic Myeloid Leukemia In Chronic Phase

Muriel Silva Moura, Katia B. Pagnano, MD, PhD, Thais Benevides, Carmino A De Souza, Sr., MD, PhD, Irene Lorand-Metze, MD, PhD, Marcia T Delamain, MD, Gislaine O. Duarte, PhD, Fernando V Pericole, MD, Priscila Percout, Maria Dias, Bruno Duarte, Paula Campos, Paola Assunção, Luciene Oliveira, Pamela Paul, Eliana Fernandes

Blood (2013) 122 (21): 5200.

https://doi.org/10.1182/blood.V122.21.5200.5200

Published: 2013

Journal Articles

Screening of Mutations in BCR-ABL Kinase Domain in Chronic Myeloid Leukemia (CML) Patients Treated with Kinase Inhibitors by Denaturing High-Performance Liquid Chromatography (D-HPLC).

Cintia C. Mascarenhas, Anderson F. Cunha, Katia B.B. Pagnano, MD, Rosana A. Silveira, Fernando F. Costa, MDPhD, Ricardo Pasquini, MDPhD, Nelma C.D. Clementino, MDPhD, Carmino A. De Souza, MDPhD

Blood (2007) 110 (11): 4580.

https://doi.org/10.1182/blood.V110.11.4580.4580

Published: 2007

Journal Articles

Brazilian Experience Using High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Relapse/Refractory Aggressive Non-Hodgkin Lymphoma (NHL).

Bruno K.L. Duarte, MD, I.S. Valente, MD, Afonso C. Vigorito, MD, Francisco J.P. Aranha, MD, Gislaine B. Oliveria, MD, Eliana C.M. Miranda, Irene Lorand-Metze, PhD, Katia B.B. Pagnano, MD, Carmino A. De Souza, MD, PhD

Blood (2007) 110 (11): 5102.

https://doi.org/10.1182/blood.V110.11.5102.5102

Published: 2007

Journal Articles

High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Salvage Treatment of Hodgkin’s Disease (HD): A Brazilian Experience.

Bruno K.L. Duarte, MD, I.S. Valente, MD, Afonso C. Vigorito, MD, Francisco J.P. Aranha, MD, Gislaine B. Oliveira, MD, Eliana C.M. Miranda, Irene Lorand-Metze, PhD, Katia B.B. Pagnano, MD, Carmino A. De Souza, MD, PhD

Blood (2007) 110 (11): 5103.

https://doi.org/10.1182/blood.V110.11.5103.5103

Published: 2007

Journal Articles

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

Francois Guilhot, Jane Apperley, Dong-Wook Kim, Eduardo O. Bullorsky, Michele Baccarani, Gail J. Roboz, Sergio Amadori, Carmino A. de Souza, Jeffrey H. Lipton, Andreas Hochhaus, Dominik Heim, Richard A. Larson, Susan Branford, Martin C. Muller, Prasheen Agarwal, Ashwin Gollerkeri, Moshe Talpaz

Blood (2007) 109 (10): 4143–4150.

https://doi.org/10.1182/blood-2006-09-046839

Published: 2007

Journal Articles

Detection of BCR-ABL Point Mutations in Patients with Chronic Myeloid Leukemia (CML) Resistant to Imatinib.

Rosana A. Silveira, Dulcineia M. Albuquerque, PhD, Angela M. Assis, Edson Ichihara, Carmino A. de Souza, MD,PhD, Fernando F. Costa, MD,PhD, Marcia T. Delamain, MD, Afonso C. Vigorito, MD,PhD, Irene Lorand-Metze, MD,PhD, Eliana Miranda, Katia B.B. Pagnano, MD,PhD

Blood (2006) 108 (11): 4817.

https://doi.org/10.1182/blood.V108.11.4817.4817

Published: 2006

Journal Articles

High-Dose Sequential Chemotherapy Versus a Less Intensive Chemotherapeutic Regimen Followed by Peripheral Blood Progenitor Cell Autografting in Patients with Advanced Hodgkin’s Disease.

Marcio Nucci, MD, Katia Urago, MD, Eliana A. Miranda, Marcia Delamain, MD, Joao T. Souto Filho, MD, Silvia F. Matte, MD, Carla M. Duarte, MD, Gislaine B. Oliveira, MD, Afonso C. Vigorito, MD, Katia B. Pagnano, MD, Angelo Maiolino, MD, Carmino A. de Souza, MD

Blood (2005) 106 (11): 5485.

https://doi.org/10.1182/blood.V106.11.5485.5485

Published: 2005

Journal Articles

High Frequency of Point Mutations of BCR/ABL Gene in CML Patients Resistant to Imatinib Therapy - Report of a Novel Mutation.

Edson Ichihara, Fernando F. Costa, MD, Natasha Busoli, Dulcineia M. Albuquerque, Irene Lorand-Metze, MD, Sara T.O. Saad, MD, Carmino A. De Souza, MD, Afonso C. Vigorito, MD, Katia B.B. Pagnano, MD

Blood (2004) 104 (11): 4661.

https://doi.org/10.1182/blood.V104.11.4661.4661

Published: 2004

Journal Articles

Inherited Mutation in Exon 2 of GATA-1 Is Associated with a Clinical and Laboratory Picture Similar to Familial Hypocellular Myelodysplastic Syndrome (MDS).

Luciana M. Hollanda, B.Sc, Carmen S.P. Lima, M.D., Ph.D, Anderson F. Cunha, Ph.D, Dulcineia M. Albuquerque, B.Sc, Margareth C. Ozelo, Ph.D, Carmino A. De Souza, Ph.D, Irene Lorand-Metze, Ph.D, Sara T.O. Saad, Ph.D., Fernando F. Costa, Ph. D.

Blood (2004) 104 (11): 3432.

https://doi.org/10.1182/blood.V104.11.3432.3432

Published: 2004

NARROW

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Evaluation of Peroxiredoxins (PRDX1, PRDX2 and PRDX6) Expression in Patients with Chronic Myeloid Leukemia (CML) Treated with Imatinib in First Line

Predictive Value Of Early Molecular Responses In Outcomes Of Patients With Chronic Myeloid Leukemia Treated With Imatinib In First-Line Therapy

Evaluation Of hOCT1expression In Patients With Chronic Myeloid Leukemia (CML) Treated With Imatinib In First Line

Multiple Myeloma Profile In Latin America: Clinical and Epidemiological Observational Study

Early Molecular Response Is Predictive Of Overall, Progression-Free and Event-Free Survival In Chronic Myeloid Leukemia Using Second-Generation Tyrosine Kinase Inhibitors After Imatinib Treatment

Metabolomic Model For Chronic Gvhd Diagnosis

Treatment Results With Dasatinib Or Nilotinib In Third Line Therapy Of Chronic Myeloid Leukemia After Failure Of Two Tyrosine Kinase Inhibitors

Evaluation Of Anemia After Long-Term Treatment With Imatinib In Chronic Myeloid Leukemia In Chronic Phase

Screening of Mutations in BCR-ABL Kinase Domain in Chronic Myeloid Leukemia (CML) Patients Treated with Kinase Inhibitors by Denaturing High-Performance Liquid Chromatography (D-HPLC).

Brazilian Experience Using High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Relapse/Refractory Aggressive Non-Hodgkin Lymphoma (NHL).

High Dose Sequential (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Salvage Treatment of Hodgkin’s Disease (HD): A Brazilian Experience.

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

Detection of BCR-ABL Point Mutations in Patients with Chronic Myeloid Leukemia (CML) Resistant to Imatinib.

High-Dose Sequential Chemotherapy Versus a Less Intensive Chemotherapeutic Regimen Followed by Peripheral Blood Progenitor Cell Autografting in Patients with Advanced Hodgkin’s Disease.

High Frequency of Point Mutations of BCR/ABL Gene in CML Patients Resistant to Imatinib Therapy - Report of a Novel Mutation.

Inherited Mutation in Exon 2 of GATA-1 Is Associated with a Clinical and Laboratory Picture Similar to Familial Hypocellular Myelodysplastic Syndrome (MDS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only